Scanning for clues to better use selective estrogen receptor modulators

Mitchell J. Machiela, Stephen J. Chanock

Research output: Contribution to journalArticlepeer-review

Abstract

Ingle and colleagues present timely findings identifying genetic variants associated with response to selective estrogen receptor modulator therapy that when substantiated in follow-up may represent an important step toward understanding estrogen-dependent induction of BRCA1 expression and advancing individualized preventive medicine in women at high risk for developing breast cancer.

Original languageEnglish (US)
Pages (from-to)728-729
Number of pages2
JournalCancer discovery
Volume3
Issue number7
DOIs
StatePublished - Jul 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Scanning for clues to better use selective estrogen receptor modulators'. Together they form a unique fingerprint.

Cite this